J
Julie Parkes
Researcher at University of Southampton
Publications - 84
Citations - 4039
Julie Parkes is an academic researcher from University of Southampton. The author has contributed to research in topics: Population & Liver disease. The author has an hindex of 21, co-authored 75 publications receiving 3290 citations. Previous affiliations of Julie Parkes include Southampton General Hospital.
Papers
More filters
Journal ArticleDOI
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.
Indra Neil Guha,Julie Parkes,Paul Roderick,Dipanker Chattopadhyay,Richard Cross,Scott Harris,Philip Kaye,Alastair D. Burt,Steve D. Ryder,Guruprasad P. Aithal,Christopher P. Day,William Rosenberg +11 more
TL;DR: The ELF panel has good diagnostic accuracy in an independent validation cohort of patients with NAFLD and the addition of established simple markers augments the diagnostic performance across different stages of fibrosis, which will potentially allow superior stratification of patients for emerging therapeutic strategies.
Journal ArticleDOI
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
Robin Poole,Oliver J. Kennedy,Paul Roderick,Jonathan A. Fallowfield,Peter C. Hayes,Julie Parkes +5 more
TL;DR: Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm.
Journal ArticleDOI
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Julie Parkes,Paul Roderick,Scott Harris,Christopher P. Day,David Mutimer,Jane Collier,Martin Lombard,Graeme J.M. Alexander,John Ramage,Geoffrey Dusheiko,Mark Wheatley,Carol Gough,Alastair D. Burt,William Rosenberg +13 more
TL;DR: Survival analysis showed that the ELF score predicts liver outcomes, with people having the highest ELF scores being significantly more likely to have clinical outcomes than those in lower-score groups.
Journal ArticleDOI
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
Ankur Srivastava,R. Gailer,R. Gailer,Sudeep Tanwar,Sudeep Tanwar,P M Trembling,P M Trembling,Julie Parkes,Alison Rodger,Deepak Suri,Douglas Thorburn,Douglas Thorburn,K. Sennett,S. Morgan,Emmanuel Tsochatzis,Emmanuel Tsochatzis,William Rosenberg,William Rosenberg +17 more
TL;DR: It is shown that established blood tests for liver fibrosis can be used in primary care to stratify patients with fatty liver disease, leading to a reduction in unnecessary referrals by 80% and greatly improving the detection of cases of advanced fibrosis and cirrhosis.
Journal ArticleDOI
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.
Valerio Nobili,Julie Parkes,G. F. Bottazzo,Matilde Marcellini,Richard Cross,Daniel Newman,Francesco Vizzutti,Massimo Pinzani,William Rosenberg +8 more
TL;DR: In pediatric patients with NAFLD, the ELF test predicted liver fibrosis stage with a high degree of sensitivity and specificity; results were superior to those reported for adults.